Adanas, CihanOzkan, SezaiDemir, Canan2025-05-102025-05-1020210030-998210.47391/JPMA.7192-s2.0-85103997935https://doi.org/10.47391/JPMA.719https://hdl.handle.net/20.500.14720/7370Demir, Canan/0000-0002-4204-9756Objective: To compare the levels of ischaemia modified albumin between osteomyelitis patients and healthy controls. Method: The cross-sectional prospective study was conducted at Van Yuzuncu Yil University, Van, Turkey, from May 2018 to May 2019, and comprised inpatients diagnosed with osteomyelitis, and healthy controls. Serum IMA concentrations were determined spectrophotometrically at 470nm wavelength. Serum ischaemia modified albumin levels were measured and compared between the patients and the controls. Data was analysed using SPSS 20. Results: Of the 77 subjects, 37(48%) were patients and 40(52%) were controls. Serum ischaemia modified albumin level in patients was significantly higher than controls (p<0.05). There was a significant correlation between ischaemia modified albumin and C-reactive protein levels (p<0.05). Conclusion: Serum ischaemia modified albumin level in patients was significantly higher than controls (p<0.05).eninfo:eu-repo/semantics/openAccessOsteomiyelitisIschaemia-Modified AlbuminReceiving Operation CurveBiomarkerC-Reactive ProteinArticle712Q4Q346146433819228WOS:000631837300003